Valuation: Embla Medical hf.

Market Cap 1.77B 11.62B 1.55B 1.44B 1.33B 2.5B 171B 2.53B 17.18B 6.72B 83.68B 6.66B 6.51B 289B P/E 2026 *
18x
P/E 2027 * 16.1x
Enterprise Value 2.19B 14.34B 1.92B 1.78B 1.64B 3.08B 211B 3.12B 21.21B 8.3B 103B 8.21B 8.04B 357B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.93x
Free-Float
36.17%
Yield 2026 *
-
Yield 2027 * -
1 day-0.37%
1 week+3.79%
Current month+2.24%
1 month+4.98%
3 months-2.14%
6 months-14.38%
Current year-15.69%
1 week 26.25
Extreme 26.25
27.85
1 month 25.55
Extreme 25.55
27.85
Current year 25
Extreme 25
33.1
1 year 25
Extreme 25
37.9
3 years 25
Extreme 25
38
5 years 25
Extreme 25
49.45
10 years 22.5
Extreme 22.5
57.8
Manager TitleAgeSince
Chief Executive Officer 48 31/03/2022
Director of Finance/CFO 60 31/08/2022
Chief Tech/Sci/R&D Officer - 23/02/2025
Director TitleAgeSince
Director/Board Member 58 31/12/2008
Chairman 68 31/12/2005
Director/Board Member 61 31/01/2008
Date Insider Type Main position Quantity % Market Cap.
22/12/25 BuyCompany 10,400 0.0024%
15/12/25 BuyCompany 45,275 0.0106%
08/12/25 BuyCompany 30,000 0.0070%
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+3.79%-14.91%-13.97% 1.77B
-0.52%-5.15%-5.56%-29.42% 19.47B
+4.74%+1.74%-8.86%-11.58% 14.66B
-4.92%-9.52%-63.84%-52.21% 5.41B
-1.16%+2.79% - - 4.07B
+0.88%+6.26%+51.28%+17.35% 1.72B
-1.30%-4.50%-41.74%-61.09% 1.17B
+1.75%-2.51%+13.16%+161.43% 442M
+30.00%+18.18% - - 293M
+5.35%-1.24%-34.23% - 166M
Average +3.45%+2.34%-13.09%+1.50% 4.92B
Weighted average by Cap. +0.78%-1.36%-12.72%-22.84%

Financials

2026 *2027 *
Net sales 1.02B 6.69B 894M 829M 763M 1.44B 98.26B 1.46B 9.89B 3.87B 48.16B 3.83B 3.75B 166B 1.1B 7.22B 966M 895M 824M 1.55B 106B 1.57B 10.69B 4.18B 52.04B 4.14B 4.05B 180B
Net income 100M 657M 87.87M 81.42M 74.94M 141M 9.65B 143M 972M 380M 4.73B 376M 368M 16.34B 110M 721M 96.43M 89.35M 82.24M 155M 10.6B 157M 1.07B 417M 5.19B 413M 404M 17.93B
Net Debt 416M 2.72B 364M 337M 311M 586M 40.02B 593M 4.03B 1.58B 19.61B 1.56B 1.53B 67.71B 356M 2.33B 312M 289M 266M 501M 34.26B 508M 3.45B 1.35B 16.79B 1.34B 1.31B 57.98B
Logo Embla Medical hf.
Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.
Employees
4,500
Date Price Change Volume
22/07/26 DKK 27.20 -0.18% 3,285
21/07/26 DKK 27.25 +3.42% 156,233
20/07/26 DKK 26.35 -0.57% 161,751
17/07/26 DKK 26.50 0.00% 104,272
16/07/26 DKK 26.50 +0.38% 69,901
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.25DKK
Average target price
33.50DKK
Spread / Average Target
+22.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMBLA Stock